American Vanguard® Corporation today announced that its crop business unit, AMVAC®, entered into a regional distribution agreement with DPH Biologicals®, a leading developer and supplier of agricultural biologicals. The agreement significantly expands American Vanguard’s GreenSolutions portfolio and increases availability of biological products throughout the U.S. while also expanding DPH Bio’s footprint into specialty crop markets.

Under the long-term agreement, AMVAC resells DPH Bio’s key products, which include TerraTrove® SP-1 Classic® and TerraTrove AmplAphex® biofertilizers as well as BellaTrove® Companion Maxx®, a novel EPA-approved biocontrol product with both fungicidal and nematocidal activity that is unique in its category. In addition, AMVAC distributes future product offerings, utilizing DPH Bio’s TerraTrove technology platform for biofertilizers and the BellaTrove platform for biocontrol products.

DPH Bio significantly strengthens its market access in the U.S. by partnering with AMVAC’s U.S. commercial and operational teams with an initial focus on specialty crop markets. With the agreement, AMVAC is servicing DPH Bio’s existing customers in the Western and Southern regions by providing enhanced commercial and technical support.

The combination of DPH Bio’s leading products with AMVAC’s GreenSolutions portfolio provides an industry-leading offering for AMVAC’s grower, distributor, and retail partners. The addition of DPH Bio’s TerraTrove products complement AMVAC’s current biostimulant portfolio, while Bella Trove Companion Maxx provides a novel biocontrol solution for AMVAC to complement its extensive crop protection portfolio.

“Our biological technology platform has been refined across millions of acres to rapidly improve soil and plant health while offering alternatives and complements to traditional fertility and crop protection programs,” said Mick Messman, Chief Executive Officer of DPH Biologicals. “We’re pleased to take the next step in our company’s evolution by partnering with AMVAC and gaining the advantages of its market access and sales team. This relationship is pivotal for more growers to access DPH Bio’s technology and enables further expansion into the rapidly growing biocontrol segment.”

Douglas (Dak) A. Kaye III, Chief Executive Officer of American Vanguard, highlighted DPH Bio’s technical know-how and experienced management team as key advantages of the distribution agreement. Kaye said, “DPH Bio, in addition to its current products, also has a great pipeline of future products. Along with our growing GreenSolutions portfolio, this collaboration has the potential to significantly increase the value, access, and use of biological products in Western and Southern U.S. crop markets for years to come.”

About DPH Biologicals

Management-owned since 2024, DPH Biologicals® is focused on advancing agriculture's shift toward a more balanced biological approach. DPH Bio emphasizes scientific research, product development, field testing and partnerships to offer proven, profitable biological products. With a legacy that spans over three decades, DPH Bio’s development capabilities and commercial reach allow novel biologicals to get to market, ultimately providing more sustainable solutions that seamlessly integrate into modern farming practices. DPH Biologicals’ portfolio is anchored by two branded platforms—BellaTrove® for biocontrols and TerraTrove® for biofertilizers—together representing a complete portfolio of biological solutions. For more information, visit www.dphbio.com

About American Vanguard Corporation

American Vanguard Corporation (AVD) is a diversified specialty and agriculture products company that develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. Over the past 20 years, through product and business acquisitions, the Company has expanded its operations into 21 countries and now has more than 1,000 product registrations in 56 nations, worldwide. To learn more about the Company, please reference www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

AMERICAN VANGUARD CONTACTS Company Jim Thompson Director of Business Development, GreenSolutions, AMVAC jimt@amvac.com (530) 760-9150

Anthony Young, Director of Investor Relations, American Vanguard anthonyy@amvac.com (949) 221-6119

Investor Representative Alpha IR Group Robert Winters robert.winters@alpha-ir.com (929) 266-6315

DPH BIOLOGICALS CONTACT Brad Holzworth SVP Strategy & Marketing bholzworth@dphbio.com (214) 548-0010

Grafico Azioni American Vanguard (NYSE:AVD)
Storico
Da Feb 2025 a Mar 2025 Clicca qui per i Grafici di American Vanguard
Grafico Azioni American Vanguard (NYSE:AVD)
Storico
Da Mar 2024 a Mar 2025 Clicca qui per i Grafici di American Vanguard